Our mission is to eliminate inaccuracy and waste when translating drug candidates to clinical trials using AI-driven, multi-disciplinary quantitative methods that predict patient outcomes.
Addressing the unmet needs of patients everywhere is our passion. Are you motivated by ownership in your work and a mission to make a difference? Do you embrace diversity? Is continuous learning part of your DNA? This is what drives the team at VeriSIM Life every day. Learn more about our mission and make up.
Dr. Jo Varshney, leader of artificial intelligence and machine learning drug development platform BIOiSIM, is recognized as Most Innovative Woman of the Year in the Stevie Awards Healthcare category.
SAN FRANCISCO, Sept. 25, 2023 /PRNewswire/ -- Jo Varshney, Founder and CEO of VeriSIM Life—developers of the world's first "credit score" for de-risking drug development— was announced as a finalist in the "Most Innovative Woman of the Year—Healthcare" category of the 20th annual Stevie® Awards for Women in Business. The Stevie Awards honor the world's top women entrepreneurs, executives, employees, and the organizations they run.